Nielsen et al. assessed the diagnostic accuracy of the AST/ALT ratio for detecting significant and advanced fibrosis among patients with NASH and liver fibrosis [33]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.